Close Menu

NEW YORK – 10x Genomics said this week it will be allowed to sell its Single Cell CNV solution and Linked-Reads products to new customers while it fights a verdict of patent infringement. However, the US Court of Appeals for the Federal Circuit denied 10x a full stay of an injunction imposed by a lower court, following a jury finding that the firm had infringed patents held by Bio-Rad Laboratories.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.